CompletedNot Applicable

Pancreatic Exocrine Insufficiency in Acute Pancreatitis

Finland50 participantsStarted 2015-09

Plain-language summary

Severe pancreatitis induces more damage in the pancreas and might therefore result reduced exocrine function leading to the insufficiency. The aim of this prospective study is to investigate development of pancreatic exocrine insufficiency in patients recovering from first attack of moderately severe or severe acute pancreatitis.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * first episode of acute pancreatitis (diagnosis based on acute onset of characteristic symptoms and elevated plasma levels of amylase and/or typical findings on CT) * severity of acute pancreatitis classified as moderately severe or severe by revised Atlanta classification of acute pancreatitis 2012 Exclusion Criteria: * previous history of acute pancreatitis * chronic pancreatitis * known pancreatic exocrine insufficiency * previous pancreatic surgery

What they're measuring

Development of pancreatic exocrine insufficiency after first attack of moderately severe or severe acute pancreatitis confirmed by fecal elastase-1 test.

Timeframe: One year after discharging from hospital

Trial details

NCT IDNCT02563080

SponsorHelsinki University Central Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02

View on ClinicalTrials.gov More Exocrine Pancreatic Insufficiency trials